Use of whole-genome association scans in disease gene identification, drug discovery and development.

Abstract excerpt

Over the past decade, whole-genome scans have been used by academia and industry as an increasingly important tool in identifying genes of disease susceptibility. Genome coverage has improved dramatically, from sparse panels of hundreds or thousands of genetic markers five to ten years ago, to panels now comprising over 500,000 markers that capture more than 80% of the genetic information in the genome....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Chromosome Mapping
• Share to Drug Delivery Systems
• Share to Drug Design